Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sysco Reports First Quarter Fiscal Year 2025 Results
-
Contract Win
-
Trace One and Covalo Partner to Streamline Product Development for Cosmetics and Personal Care Brands
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
LED Lighting and EV Charging Solutions Provider Orion Previews Q2’25 Results and Updates FY 2025 Outlook in Anticipation of LD Micro Investor Presentation Webcast Today at 8:30 a.m. PT
-
ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs
-
Google Chrome leads on Softonic’s most downloaded internet programme ranking for 2024
-
Bybit Card Expands Into New Regions, Offering Seamless and Rewarding International Crypto Payments
-
Praxis Bioresearch Obtains FDA Clearance On the IND Application for Its Lead Candidate PRX-P4-003 In Alzheimer’s Disease Apathy
-
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigat
-
Magnet Recycling Demo Plant Update and Warrant Extension
-
New OREA Whitepaper Offers Bold Policy Recommendations to Raise the Bar for Ontario Real Estate
-
Entrée Resources Announces Commencement of Underground Development on Entrée/Oyu Tolgoi JV Property and Provides Corporate Update
-
DT Midstream Reports Strong Third Quarter 2024 Results; Raises Adjusted EBITDA Guidance
-
ZenaTech Enters the Drone Sensor and Components Market Establishing a New Taiwan Subsidiary to Win More US Defense Contracts for Its AI Drones
-
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
-
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
-
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
-
Global Crossing Airlines Sets Third Quarter 2024 Conference Call for November 7, 2024 at 8:30 a.m. ET
-
Territorial Reaffirms Board of Directors Recommendation that Territorial Shareholders Vote “FOR” Hope Bancorp Merger
-
ZenaTech Enters the Drone Sensor and Components Market Establishing a New Taiwan Subsidiary to Win More US Defense Contracts for Its AI Drones
-
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
-
Streamline Health® Adds Quality Module to Third eValuator™ Client
-
Cornerstone Financing announces $285 million financing from Aquiline and Nomura
-
23andMe Appoints Three New Independent Directors to Board
-
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
-
Ollie’s Bargain Outlet Acquires Additional Former Big Lots Stores
-
Magna Debuts Scalable, Eco-Friendly ICE to Hybrid Transmission for European OEM
-
Hubbell Reports Third Quarter 2024 Results
-
CareMed Has Been Selected as a National Specialty Pharmacy Partner for Lecanemab-irmb (Leqembi®)
-
Polar Power Announces Preliminary 2024 Third Quarter Financial Results: Expected Net Sales of $4.7 - $5.2 Million and Gross Margin of 26%-32%
-
Fujifilm Launches New ECHELON Synergy 1.5T MRI System Software with AI Powered Workflow Enhancements
-
Ardena Expands Bioanalytical Services in Europe
-
Updated version of the company's articles of association
-
Verde's assays of over 1,500m of drilling find rare earths up to 12,487 ppm TREO and 3,357 ppm MREO
-
Bitget Wallet Launches Babylon Staking Program with Billion-Point Airdrop
-
H&E Rentals Reports Third Quarter 2024 Results
-
Vara Raises $8.9M in Funding While Expanding AI-Enabled Early Breast Cancer Detection to India
-
CECO Environmental to Acquire Profire Energy for $125 Million
-
Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term Profitability
-
Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With
-
Evergold Options the Rockland Gold Property to Wolfden, and Wolfden Prepares to Drill
-
BioXcel Therapeutics to Present at ThinkEquity Conference
-
SeekOut Announces CHRO Council Workshop Series to Empower Talent Leaders
-
Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board
-
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
-
2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
-
Captivision Announces Venture at Dream Hollywood Hotel
-
Beneficient to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
